Bioventus (BVS:LSE) Annual Reports & Investor Relations Material

Overview

Bioventus Inc., a medical device company based in Durham, North Carolina, is dedicated to advancing medical treatments that enhance the body's natural healing process, both in the United States and internationally. The company offers a variety of pain treatments, including non-surgical joint pain injection therapies and peripheral nerve stimulation products, as well as innovative surgical solutions such as bone graft substitutes to fuse and grow bones and ultrasonic medical devices for precise bone sculpting, removal of tumors, and tissue debridement. Bioventus also provides restorative therapies that include bone healing systems, skin allografts, and products to support the healing of wounds. The company's devices are employed by a wide range of physicians, spanning the orthopedic continuum from sports medicine, total joint reconstruction, and hand and upper extremities to foot and ankle, podiatric surgery, trauma, spine, and neurosurgery in a variety of settings, including physician offices or clinics, ambulatory surgical centers, and hospitals. Since its establishment in 2011, Bioventus has been a driving force in the medical field, seeking to empower patients' recoveries through cutting-edge therapies.

Frequently Asked Questions

What is Bioventus's ticker?

Bioventus's ticker is BVS

What exchange is Bioventus traded on?

The company's shares trade on the LSE stock exchange

Where are Bioventus's headquarters?

They are based in West Malling, England

How many employees does Bioventus have?

There are 1001-5000 employees working at Bioventus

What is Bioventus's website?

It is bioventus.com/about-us

What type of sector is Bioventus?

Bioventus is in the Industrial Goods sector

What type of industry is Bioventus?

Bioventus is in the Residential Construction industry

Who are Bioventus's peers and competitors?

The following five companies are Bioventus's industry peers:

- Bioventus

- Countryside Partnerships

- Henry Boot plc

- Watkin Jones

- M/I Homes